Daniel J. Skiest

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

Iván O. Rosas, Norbert Bräu, Michael R. Waters et al. · New England Journal of Medicine · 2021 · 1.1K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +13

Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

Schlomo Staszewski, Javier O Morales-Ramirez, Karen T. Tashima et al. · New England Journal of Medicine · 1999 · 1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 381 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort

K. R. Robertson, Zhaohui Su, David M. Margolis et al. · Neurology · 2010 · 212 citations · Full text

Medicine, Neurology, Neuroscience +13

The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

Golnaz Namazi, Jesse Fajnzylber, Evgenia Aga et al. · The Journal of Infectious Diseases · 2018 · 205 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +13